Advertisement
Discussion| Volume 9, ISSUE 3, P118-123, September 1999

Current aspects of cervical screening

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The cervical screening programme in the UK has had a long and complicated gestation. It was unplanned and has been unloved, and, initially, not surprisingly, failed to thrive. It was then taken in hand, given firm guidance and began to improve. It continues to suffer from misunderstanding and the effects of the poor handling in the past, but with careful supervision and monitoring it is beginning to be recognized as one of the most successful medical screening programmes in the world.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Obstetrics, Gynaecology and Reproductive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • British Society for Clinical Cytology. History of the British Society for Clinical Cytology
        4th edn. British Society for Clinical Cytology Handbook. 1996
        • Department of Health and Social Security
        Preventive medicine.
        Committee of Public Accounts, 1985/1986 (HC 413)
        • National Audit Office
        Cervical and breast screening in England.
        1991/1992 (HC 236)
        • NHS
        4th edn. Guidelines for clinical practice and programme management. National Co-ordinating Network of the NHS Cervical Screening Programme, 1992
        • Buckley C.H.
        • Herbert A.
        • Johnson J.
        • et al.
        Borderline nuclear changes in cervical smears: guidelines on their recognition and management.
        J Clin Pathol. 1994; 47: 481-492
        • NHS
        Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology.
        NHS Cervical Screening Programme. Publication No. 1. October 1995;
        • NHS
        Standards and quality in colposcopy.
        NHS Cervical Screening Programme. Publication No. 2. January 1996;
        • NHS
        Quality assurance guidelines for the cervical screening programme.
        NHS Cervical Screening Programme. Publication No. 3. January 1996;
        • Department of Health
        Cervical Screening Programme, England: 1996–1997.
        Statistical Bulletin. December 1997;
        • NHS
        Guidelines for clinical practice and programme management.
        NHS Cervical Screening Programme. Publication No. 8. December 1997;
        • British Society for Clinical Cytology
        Recommended code of practice for laboratories providing a cytopathology service.
        Cytopathology. 1997; 8: 1-25
      1. NHS. Cervical Screening Programme. Review 1998. NHS Cervical Screening Programme

        • Department of Health
        Cervical Screening Programme, England: 1997–1998.
        Statistical Bulletin. January 1999;
        • Office for National Statistics Monitor
        Population and healtl MB 1 98/2. July 1998;
        • Koss L.G.
        The Papanicolaou test for cervical cancer detection: a triumph and a tragedy.
        JAMA. 1989; 261: 737-743
        • Mitchell H.
        • Medley G.
        Differences between Papanicolaou smears with correct and incorrect diagnoses.
        Cytopathology. 1995; 6: 368-375
      2. Report of the Chief Medical Officer's Action Team on Cervical Screening. Department of Health, August 1998
        • Cuzick J.
        • Szarewski A.
        • Terry G.
        • et al.
        Human papilloma virus testing in primary cervical screening.
        Lancet. 1995; 345: 1533-1536